import React from 'react';
import '../styles/BlogPostPage.css';
import bacteriophagesImage from '../media/bacteriophages_compressed.webp';
import BacteriophageDiagram from '../media/bacteriophage-diagram.webp'
import '../styles/BacteriophageBlog.css'

export const metadata = {
  title: 'Exploring Bacteriophages: Nature\'s Tiny Warriors',
  date: '2024-03-20',
  category: 'Science',
  slug: 'bacteriophages-research',
  coverImage: bacteriophagesImage
};

const BacteriophagesResearch: React.FC = () => {
  return (
    <div className="blog-post">
      <div className="blog-content">
        <div className="blog-meta">
          <span className="blog-date">{metadata.date}</span>
          <span className="blog-category">{metadata.category}</span>
        </div>
        <h1>{metadata.title}</h1>
        <div className="blog-text">
          <p>
            We have been using <a href="https://www.sciencedirect.com/science/article/pii/S1369527419300190">antibiotics</a> to
            treat infections since the 1930s, and as such <a href="https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance#:~:
            // text=The%20misuse%20and%20overuse%20of,development%20of%20drug%2Dresistant%20pathogens.">antibiotic-resistant bacteria</a>
            is becomming evermore of a common occurrence. But hold hope, becase for fighting bacteria antibiotics may have an
            alternative: <i><a href="https://www.britannica.com/science/bacteriophage">bacteriophages</a></i>.
          </p>
          
          <h2>What are <i>Bacteriophages</i>?</h2>
          <div className='about-phages'>
          <p>
            Bacteriophages are specialized <a href="https://www.britannica.com/science/virus">viruses</a> that only target bacteria. Given
             that they are viruses, they are technically not <i>alive</i>, and need a host to survive and replicate. 
             They inject their genetic information into a <i>specific</i> bacteria, forcing it to produce new phages until
             it dies. 
          </p>
          <img className='phage-diagram' src={BacteriophageDiagram} alt="bactiophage-diagram"/>
          </div> 
          <p>Due to their predatory relationship against bacteria, bacteriophages play a vital role in micribiome populations
            everywhere, including in your stomach.
          </p>

          <h2>So Whats the Big Deal?</h2>
          <h3><i>Bacteriophages as an Alternative to Antibiotics</i></h3>
          <p>Bacteriophages have undergone study for medical purposes for ~100 years with promising results. The <i>National Institute of Health</i> article, <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5547374/">
            Phage therapy: An alternative to antibiotics in the age of multi-drug resistance</a>, references
            a number large number of studies that all show positive results for phage-therapy, which you can see below:
          </p>
          
          <div className="table-container">
            <table className="comparison-table">
              <caption>Table 1: Published findings on phage therapy in human and animal studies</caption>
              <thead>
                <tr>
                  <th>Causative Agent</th>
                  <th>Model</th>
                  <th>Condition</th>
                  <th>Route</th>
                  <th>Result Summary</th>
                  <th>Ref</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Shigella dysenteriae</td>
                  <td>Human</td>
                  <td>Dysentery</td>
                  <td>Oral</td>
                  <td>All four treated individuals recovered after 24 h</td>
                  <td><a href="https://doi.org/10.1016/B978-0-12-394438-2.00001-3" target="_blank" rel="noopener noreferrer">[1]</a></td>
                </tr>
                <tr>
                  <td>Vibrio cholerae</td>
                  <td>Human</td>
                  <td>Cholera</td>
                  <td>Oral</td>
                  <td>68 of 73 survived in treatment group and only 44 of 118 in control group</td>
                  <td><a href="https://doi.org/10.1016/B978-0-12-394438-2.00001-3" target="_blank" rel="noopener noreferrer">[1]</a></td>
                </tr>
                <tr>
                  <td>Pseudomonas aeruginosa</td>
                  <td>Murine</td>
                  <td>Sepsis</td>
                  <td>Oral</td>
                  <td>66.7% reduced mortality</td>
                  <td><a href="https://doi.org/10.1128/AAC.00635-06" target="_blank" rel="noopener noreferrer">[38]</a></td>
                </tr>
                <tr>
                  <td>Clostridium difficile</td>
                  <td>Hamster</td>
                  <td>Ileocecitis</td>
                  <td>Oral</td>
                  <td>Co-administration with C. difficile prevented infection</td>
                  <td><a href="https://scholar.google.com/scholar_lookup?journal=Anaerobe&title=Prevention%20of%20Clostridium%20difficile-induced%20ileocecitis%20with%20bacteriophage&author=V%20Ramesh&author=JA%20Fralick&author=RD%20Rolfe&volume=5&publication_year=1999&pages=69-78&" target="_blank" rel="noopener noreferrer">[39]</a></td>
                </tr>
                <tr>
                  <td>Clostridium difficile</td>
                  <td>Hamster</td>
                  <td>Ileocecitis</td>
                  <td>Oral</td>
                  <td>Dose every 8 h for 72 h; 92% reduced mortality</td>
                  <td><a href="https://scholar.google.com/scholar_lookup?journal=Anaerobe&title=Prevention%20of%20Clostridium%20difficile-induced%20ileocecitis%20with%20bacteriophage&author=V%20Ramesh&author=JA%20Fralick&author=RD%20Rolfe&volume=5&publication_year=1999&pages=69-78&" target="_blank" rel="noopener noreferrer">[39]</a></td>
                </tr>
                <tr>
                  <td>Vancomycin-resistant Enterococcus faecium</td>
                  <td>Murine</td>
                  <td>Bacteremia</td>
                  <td>i.p.</td>
                  <td>100% reduced mortality</td>
                  <td><a href="https://doi.org/10.1128/IAI.70.1.204-210.2002" target="_blank" rel="noopener noreferrer">[41]</a></td>
                </tr>
                <tr>
                  <td>Î²-lactamase producing Escherichia coli</td>
                  <td>Murine</td>
                  <td>Bacteremia</td>
                  <td>i.p.</td>
                  <td>100% reduced mortality</td>
                  <td><a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Med&title=Therapeutic%20effectiveness%20of%20bacteriophages%20in%20the%20rescue%20of%20mice%20with%20extended%20spectrum%20beta-lactamase-producing%20Escherichia%20coli%20bacteremia&author=J%20Wang&author=B%20Hu&author=M%20Xu&author=Q%20Yan&author=S%20Liu&volume=17&publication_year=2006&pages=347-355&pmid=16391836&" target="_blank" rel="noopener noreferrer">[42]</a></td>
                </tr>
                <tr>
                  <td>Imipenem-resistant Pseudomonas aeruginosa</td>
                  <td>Murine</td>
                  <td>Bacteremia</td>
                  <td>i.p.</td>
                  <td>100% reduced mortality</td>
                  <td><a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Med&title=Therapeutic%20effectiveness%20of%20bacteriophages%20in%20the%20rescue%20of%20mice%20with%20extended%20spectrum%20beta-lactamase-producing%20Escherichia%20coli%20bacteremia&author=J%20Wang&author=B%20Hu&author=M%20Xu&author=Q%20Yan&author=S%20Liu&volume=17&publication_year=2006&pages=347-355&pmid=16391836&" target="_blank" rel="noopener noreferrer">[43]</a></td>
                </tr>
                <tr>
                  <td>Acinetobacter baumannii, Pseudomonas aeruginosa and Staphylococcus aureus</td>
                  <td>Murine</td>
                  <td>Sepsis</td>
                  <td>i.p.</td>
                  <td>Animals protected against fatal dose of A. baumannii and P. aeruginosa but not S. aureus</td>
                  <td><a href="https://doi.org/10.1099/00222615-37-4-258" target="_blank" rel="noopener noreferrer">[44]</a></td>
                </tr>
                <tr>
                  <td>Escherichia coli</td>
                  <td>Murine</td>
                  <td>Meningitis and Sepsis</td>
                  <td>i.p. or s.c.</td>
                  <td>100% and 50% reduced mortality for meningitis and sepsis, respectively</td>
                  <td><a href="https://doi.org/10.1128/AAC.06330-11" target="_blank" rel="noopener noreferrer">[45]</a></td>
                </tr>
                <tr>
                  <td>MDR Vibrio parahaemolyticus</td>
                  <td>Murine</td>
                  <td>Sepsis</td>
                  <td>i.p. and oral</td>
                  <td>92% and 84% reduced mortality for i.p. and oral routes, respectively</td>
                  <td><a href="https://doi.org/10.1093/infdis/jiu059" target="_blank" rel="noopener noreferrer">[46]</a></td>
                </tr>
                <tr>
                  <td>S. aureus</td>
                  <td>Rabbit</td>
                  <td>Wound infection</td>
                  <td>s.c.</td>
                  <td>Co-administration with S. aureus prevented infection</td>
                  <td><a href="https://doi.org/10.1128/AAC.49.3.1220-1221.2005" target="_blank" rel="noopener noreferrer">[47]</a></td>
                </tr>
                <tr>
                  <td>MDR S. aureus</td>
                  <td>Human</td>
                  <td>Diabetic foot ulcer</td>
                  <td>Topical</td>
                  <td>All 6 treated patients recovered</td>
                  <td><a href="https://scholar.google.com/scholar_lookup?journal=J%20Wound%20Care&title=Bacteriophage%20treatment%20of%20intransigent%20diabetic%20toe%20ulcers:%20a%20case%20series&author=R%20Fish&author=E%20Kutter&author=G%20Wheat&author=B%20Blasdel&author=M%20Kutateladze&volume=25%20Suppl%207&publication_year=2016&pages=S27-S33&" target="_blank" rel="noopener noreferrer">[50]</a></td>
                </tr>
                <tr>
                  <td>Unclassified bacterial dysentery</td>
                  <td>Human</td>
                  <td>Dysentery</td>
                  <td>Oral</td>
                  <td>Phage cocktail improved symptoms in 74% of 219 patients</td>
                  <td><a href="https://scholar.google.com/scholar_lookup?journal=Microbiol%20Australia&title=Bacteriophage%20therapy:%20experience%20from%20the%20Eliava%20Institute,%20Georgia&author=N%20Chanishvili&author=R%20Sharp&volume=29&publication_year=2008&pages=96-101&" target="_blank" rel="noopener noreferrer">[51]</a></td>
                </tr>
                <tr>
                  <td>Salmonella typhi</td>
                  <td>Human</td>
                  <td>Typhoid</td>
                  <td>Oral</td>
                  <td>In a cohort of 18,577 children, phage treatment was associated with a 5-fold decrease in typhoid incidence compared to placebo</td>
                  <td><a href="https://doi.org/10.1016/j.medmal.2008.06.023" target="_blank" rel="noopener noreferrer">[49]</a></td>
                </tr>
                <tr>
                  <td>Antibiotic-resistant Pseudomonas aeruginosa</td>
                  <td>Human</td>
                  <td>Chronic Otitis</td>
                  <td>Oral</td>
                  <td>Phage treatment safe and symptoms improved in a double-blind, placebo-controlled Phase I/II trial</td>
                  <td><a href="https://doi.org/10.1111/j.1749-4486.2009.01973.x" target="_blank" rel="noopener noreferrer">[61]</a></td>
                </tr>
              </tbody>
            </table>
            <div className="table-citation">
              Source: Adapted from <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547374/" target="_blank" rel="noopener noreferrer">
              "Phage therapy: An alternative to antibiotics in the age of multi-drug resistance"</a>, National Institutes of Health (NIH).
            </div>
          </div>
          
          <h2>Future Research Directions</h2>
          <p>
            Current research focuses on:
          </p>
          <ul>
            <li>Engineering phages for enhanced therapeutic properties</li>
            <li>Understanding phage-bacteria interactions</li>
            <li>Developing phage-based diagnostics</li>
            <li>Exploring phage applications in agriculture</li>
          </ul>

          <p>
            As we continue to explore the potential of bacteriophages, they may become 
            increasingly important tools in our fight against bacterial infections and 
            in maintaining microbial balance in various environments.
          </p>
        </div>
      </div>
    </div>
  );
};

export default BacteriophagesResearch; 